 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 150
Date: February 9, 2024
Since our hypothetical patient Harvey has developed a modest following of his own, I thought I had best report on new developments. Harvey's latest experience coincides with recently published reports on new adverse effects of Rituxan therapy.
While the post-marketing surveillance of Rituxan has so far identified only a small percent of patients having these problem, the danger is high and very real for these patients, and therefore worth discussing. Please make sure you read this latest article on our website clltopics.org if you have had Rituxan therapy recently, especially if you have experienced skin and mucosal problems, or GI tract / pulmonary problems a few days to a couple of months after end of therapy. These adverse effects are in addition to previously identified warnings about delayed onset neutropenia and possible viral reactivation of hepatitis. In patients where these newly identified symptoms of drug hypersensitivity is confirmed, Rituxan may be contra-indicated in the future.
Happy Valentine's Day! I wish I had better news to share with you today.
Be well,
Chaya
______
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
